This provides a rationale for exploring the possible use of targeted therapies for the inhibition of the PI3K/PTEN/Akt and TSC/mTOR signaling cascades in certain ovarian dysfunctions including infertility and POF. This evidence concerns the gene AKT1 and premature menopause.